Objectives The aim was to determine the mode of presentation and 30 day procedural risks
in 4418 patients with 4743 carotid body tumours (CBTs) undergoing surgical excision …

Background Carotid body tumor (CBT) is a rare neoplasm that has been increasingly
studied during the last decades; nevertheless, it continues to be a topic of controversy. This …

Objective: To report our experience in the management of CBTs and review the literature.
Materials and Methods: 56 CBTs were operated upon over a period of 25 years. Surgical …

Objective Most patients presenting with carotid body tumors (CBTs) seek medical attention
when tumors have grown to exceed Shamblin I stage, rendering surgery a challenging …

There has been no attempt to clarify the status of patients with carotid body tumor (CBT) in
Japan. This multi‑institutional survey analyzed patients with CBT throughout Japan by …

Background Paragangliomas are rare neuroendocrine tumors, representing 0.03% of all
tumors. Half of them develop in the head and neck, and among these 50% are sporadic …

Background Although carotid body tumors (CBTs) are rare, they attract particular attention
because of their propensity for malignant transformation and the high surgical risk. Because …

Malignant carotid body tumors (MCBT) are rare and diagnosed after detection of nodal or
distant metastases. This systematic review (SR) focuses on MCBT initially approached by …

Carotid body tumors (CBTs) are rare types of extra-adrenal paragangliomas, which originate
from the neuroendocrine cells of the adventitial layer of carotid bifurcation. An 8-year-old girl …

Objective: Carotid body tumors (CBTs) are rare hypervascular benign tumors that originate
from the paraganglia at the carotid bifurcation. The red cell distribution width (RDW) …